cyclosporine has been researched along with Denys-Drash Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuroczycka-Saniutycz, E; Wasilewska, AM; Zoch-Zwierz, W | 1 |
| Querfeld, U; Stefanidis, CJ | 1 |
| Jiang, XY; Mo, Y; Sun, LZ; Wang, HY; Yang, J; Yue, ZH | 1 |
1 review(s) available for cyclosporine and Denys-Drash Syndrome
| Article | Year |
|---|---|
The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Child, Preschool; Cyclosporine; Denys-Drash Syndrome; Drug Resistance; Drug Therapy, Combination; Female; Frasier Syndrome; Genes, Wilms Tumor; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methylprednisolone; Molecular Targeted Therapy; Mutation; Nephrotic Syndrome; Podocytes | 2011 |
2 other study(ies) available for cyclosporine and Denys-Drash Syndrome
| Article | Year |
|---|---|
Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations.
Topics: Cyclosporine; Denys-Drash Syndrome; Female; Genes, Wilms Tumor; Humans; Immunosuppressive Agents; Infant; Mutation; Nephrotic Syndrome; Remission Induction | 2011 |
[Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].
Topics: Cyclosporine; Denys-Drash Syndrome; Fatal Outcome; Female; Genes, Wilms Tumor; Heterozygote; Humans; Infant; Male; Mutation; Nephrotic Syndrome; Proteinuria; Sclerosis; Tacrolimus; Treatment Outcome; Wilms Tumor; WT1 Proteins | 2012 |